^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    UCART19

    i
    Other names: UCART19, chimeric antigen receptor (CAR)-modified CD19-targeted allogeneic T cells, S68587, UCART 19, universal chimeric antigen receptor T cell 19, universal TALEN gene-edited CART19 cells, TCR/CD52-deficient RQR8+ CD19-CAR+ T cells, UCART-19, S-68587, CD19CAR/RQR8+_TCRαβ–_T-cell, S95023
    Associations
    News
    Trials
    Company:
    Allogene Therap, Cellectis, Pfizer, Servier
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials